These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 13716364

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. 5-hydroxyindole levels in the blood and CSF in Down's syndrome, phenylketonuria and severe mental retardation.
    Tu J, Partington MW.
    Dev Med Child Neurol; 1972 Aug; 14(4):457-66. PubMed ID: 4262081
    [No Abstract] [Full Text] [Related]

  • 5. Effect of reserpine in therapeutic dosage on excretion of 5-hydroxyindoleacetic acid.
    TODRICK A, DICK M, TAIT AC.
    Br Med J; 1958 Mar 01; 1(5069):496-9. PubMed ID: 13510706
    [No Abstract] [Full Text] [Related]

  • 6. [The effect of radiotherapy on 5-hydroxyindoleacetic acid excretion].
    BETTENDORF G, MOJE AP, SCHMERMUND HJ.
    Strahlentherapie; 1962 Mar 01; 117():370-6. PubMed ID: 13868651
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Studies on conversion of phenylalanine to tyrosine in phenylpyruvic oligophrenia.
    WALLACE HW, MOLDAVE K, MEISTER A.
    Proc Soc Exp Biol Med; 1957 Apr 01; 94(4):632-3. PubMed ID: 13431902
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Competitive inhibition of mammalian tyrosinase by phenylalanine and its relationship to hair pigmentation in phenylketonuria.
    FITZPATRICK TB, MIYAMOTO M.
    Nature; 1957 Jan 26; 179(4552):199-200. PubMed ID: 13400136
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Increase of excretion of 5-hydroxyindolacetic acid in smokers].
    SCHIEVELBEIN H, SURBERG U, WERLE E.
    Klin Wochenschr; 1962 Jan 01; 40():52-3. PubMed ID: 14498355
    [No Abstract] [Full Text] [Related]

  • 15. [Excretion of 5-hydroxyindolacetic acid in glaucoma patients].
    SAMAN K, LAHN V, VIRT S.
    Cesk Oftalmol; 1961 Nov 01; 17():487-94. PubMed ID: 14496566
    [No Abstract] [Full Text] [Related]

  • 16. Phenylketonuria or phenylpyruvic oligophrenia in the rat: behavioural and biochemical correlates.
    Perez VJ.
    J Ment Defic Res; 1965 Sep 01; 9(3):170-82. PubMed ID: 5892858
    [No Abstract] [Full Text] [Related]

  • 17. [5-Hydroxytryptamine and diseases of the digestive system. 2. Excretion of 5-hydroxyindoleacetic acid in the urine, clinical and bioptic-morphological results of research].
    SCHMID E, ROSENBUSCH U, HEINKEL K, SCHWEMMLE K, SCHOEN H.
    Gastroenterologia; 1961 Sep 01; 96():275-90. PubMed ID: 14498636
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The effect of reserpine and neostigmine on the excretion of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in rabbits.
    PAASONEN MK, PELTOLA P, VANHAKARTANO PA.
    Ann Med Exp Biol Fenn; 1960 Sep 01; 38():220-6. PubMed ID: 14429626
    [No Abstract] [Full Text] [Related]

  • 20. [The excretion of the serotonin catabolite 5-hydroxyindolacetic acid in pregnancy].
    BETTENDORF G, SCHANDER U, SCHMERMUND HJ.
    Klin Wochenschr; 1959 Sep 01; 37():936. PubMed ID: 13800193
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.